Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

China has sent a new crew to its Tiangong space station, including its youngest ever taikonaut, along with the first live ...

China is set to launch the Shenzhou-21 spaceship to its space station late Friday, sending a new crew of three astronauts and four mice. The crew will take off from the Jiuquan launch center ...

TB-500 (a fragment of Thymosin Beta-4) and BPC-157 (Body Protection Compound) are two naturally derived peptide chains that have been the subject of significant academic interest. Each has been ...

The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...

The Germany 3D bioprinted human tissue market is on the cusp of a transformative decade, projected to grow from USD 70.7 ...

Contraception and family planning are vital aspects of sexual and reproductive health and rights. Despite major advances in ...

If gene-editing tomatoes proves effective, researchers hope to bring the first “sunshine tomato” to market within three years ...

Novo Nordisk A/S to scupper its acquisition of Metsera Inc., with an unsolicited $9 billion offer for the anti-obesity specialist. That trumps Pfizer’s agreed bid made in September, which valued New ...

Sen. Bill Cassidy, MD (R-La.), chair of the committee, applauded medical innovations of the last few decades including ...

About Sensei Biotherapeutics Sensei Biotherapeutics (Nasdaq: SNSE) is a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer ...